It is December 2022. You work as a financial analyst for Merck & Co. and are tasked with the due diligence on the proposed acquisition of a biotech startup. You estimated the following cash flows for the startup: Expected free cash flow ($ million) Year (end of year) 2023 67.5 2024 101.25 2025 131.63 2026 157.95 2027 173.75 After 2027, cash flows are expected to grow by 3% per year. Based on the riskiness of your industry, you think that your weighted average cost of capital is 17%. The biotech firm has 5 million shares and bonds worth $120 million outstanding. Attempt 1/10 for 10 pts. Part 1 What is the horizon value, i.e., the present value of all free cash flows from 2028 to infinity expressed in 2027-dollars (in $ million)? 0+ decimals Submit . Attempt 1/10 for 10 pts. Part 2 What is the total value of the company (in $ million)